Jazz Pharmaceuticals Aktie
125,20
EUR
-0,75
EUR
-0,60
%
137,97
USD
+1,89
USD
+1,39
%
Werbung
Jazz Pharmaceuticals Aktie Analyse
14.12.18 | Jazz Pharmaceuticals Peer Perform | Wolfe Research | |
23.03.18 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
05.12.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
10.11.17 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
25.08.17 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
31.05.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
06.04.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
24.02.16 | Jazz Pharmaceuticals Neutral | Mizuho | |
Werbung
|
|||
10.11.15 | Jazz Pharmaceuticals Neutral | Mizuho |
Werbung
Werbung